Skip to content
by Legal Desire
19 March 2021

Hogan Lovells advises Gilead Sciences in long-acting HIV therapy collaboration agreement with Merck

Advising firms

Deal team

7 lawyers named
LawyerFirmSeniorityPracticeOffice
Cullen Taylor Lead Hogan Lovells Partner Life Sciences Transactions Northern Virginia
Lauren Battaglia Hogan Lovells Partner Antitrust, Competition, and Economic Regulation Washington, D.C.
Falk Schöning Hogan Lovells Partner Antitrust, Competition, and Economic Regulation Brussels
Dan Davidson Hogan Lovells Counsel Tax, Pensions & Benefits Washington, D.C.
Nadia Aksentijevich Hogan Lovells Senior associate Intellectual Property, Media, Telecommunications Washington, D.C.
Rachel Eisen Hogan Lovells Associate Intellectual Property, Media, Telecommunications Northern Virginia
Estefania McCarroll Hogan Lovells Associate Intellectual Property, Media, Telecommunications Northern Virginia

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Gilead SciencesJoint venture party
Counterparties
Merck & Co. (Joint venture party)